Equity Capital Markets

Company · CIK 1340752

Molecular Insight Pharmaceuticals, Inc.

CIK1340752 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inMA
Business addressMA
Listedno ticker on SEC record today
First annual or quarterly report2007-04-02

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-150788
ShelfEffective
 2008-05-092011-05-043
333-161601
ShelfEffective
 2009-08-282011-05-043
333-129570
IPOFinal prospectus
 2005-11-082007-02-0210

Filings

16
FiledFilingRegistrationAccession
2011-05-04EFFECTDeclared effective 333-1616019999999995-11-001385
2011-05-04EFFECTDeclared effective 333-1507889999999995-11-001382
2009-09-11EFFECTDeclared effective 333-1616019999999995-09-002538
2009-08-28S-3Shelf registered 333-1616010001193125-09-183867
2008-06-16EFFECTDeclared effective 333-1507889999999995-08-001909
2008-05-09S-3Shelf registered 333-1507880000950135-08-003588
2007-02-02424B4Final prospectus 333-1295700000950135-07-000486
2007-02-01EFFECTDeclared effective 333-1295709999999995-07-000398
2007-02-01S-1/AAmendment 333-1295700000950135-07-000458
2007-01-30S-1/AAmendment 333-1295700000950135-07-000418
2007-01-25S-1/AAmendment 333-1295700000950135-07-000326
2007-01-22S-1/AAmendment 333-1295700000950135-07-000258
2007-01-03S-1/AAmendment 333-1295700000950135-07-000023
2006-12-08S-1/AAmendment 333-1295700000950135-06-007330
2006-01-19S-1/AAmendment 333-1295700000950135-06-000212
2005-11-08S-1Registration filed 333-1295700000950135-05-006309

All filings of this company · CSV